ALPS
Price
$0.94
Change
-$0.02 (-2.08%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
164.72M
Intraday BUY SELL Signals
VNDA
Price
$7.59
Change
-$0.46 (-5.71%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
475.73M
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPS vs VNDA

Header iconALPS vs VNDA Comparison
Open Charts ALPS vs VNDABanner chart's image
Alps Group
Price$0.94
Change-$0.02 (-2.08%)
Volume$3.88K
Capitalization164.72M
Vanda Pharmaceuticals
Price$7.59
Change-$0.46 (-5.71%)
Volume$13.16K
Capitalization475.73M
ALPS vs VNDA Comparison Chart in %
ALPS
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALPS vs. VNDA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPS is a Hold and VNDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ALPS: $0.96 vs. VNDA: $8.05)
Brand notoriety: ALPS and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPS: 95% vs. VNDA: 63%
Market capitalization -- ALPS: $164.72M vs. VNDA: $475.73M
ALPS [@Biotechnology] is valued at $164.72M. VNDA’s [@Biotechnology] market capitalization is $475.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPS’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ALPS’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than ALPS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPS’s TA Score shows that 2 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • ALPS’s TA Score: 2 bullish, 4 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALPS is a better buy in the short-term than VNDA.

Price Growth

ALPS (@Biotechnology) experienced а -1.83% price change this week, while VNDA (@Biotechnology) price change was +0.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

VNDA is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($476M) has a higher market cap than ALPS($165M). ALPS YTD gains are higher at: 10.881 vs. VNDA (-8.730).
ALPSVNDAALPS / VNDA
Capitalization165M476M35%
EBITDAN/A-113.07M-
Gain YTD10.881-8.730-125%
P/E RatioN/A126.00-
RevenueN/A212M-
Total CashN/A294M-
Total DebtN/A10.9M-
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALPSVNDA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
14%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
10%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
19%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 7 days ago
48%
Bearish Trend 10 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
25%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ALPS
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHIAX22.530.18
+0.81%
Diamond Hill International Inv
RALIX11.260.02
+0.18%
Lazard Real Assets Instl
MPLAX16.93-0.03
-0.18%
Praxis International Index A
JHIGX36.99-0.07
-0.19%
JHancock International Growth R2
MUERX35.75-0.37
-1.02%
MFS Blended Research Core Equity R1

ALPS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPS has been loosely correlated with APLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPS jumps, then APLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPS
1D Price
Change %
ALPS100%
-2.09%
APLS - ALPS
48%
Loosely correlated
+2.15%
ADTX - ALPS
26%
Poorly correlated
-9.66%
VNDA - ALPS
25%
Poorly correlated
+4.01%
VERU - ALPS
24%
Poorly correlated
-0.39%
TCRX - ALPS
23%
Poorly correlated
-2.37%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IVF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+4.01%
IVF - VNDA
40%
Loosely correlated
-6.45%
OLMA - VNDA
37%
Loosely correlated
+1.91%
MGTX - VNDA
37%
Loosely correlated
+2.68%
VCYT - VNDA
36%
Loosely correlated
-1.10%
JAZZ - VNDA
36%
Loosely correlated
-0.27%
More